Learn how R&D teams boost research impact with
trusted knowledge
Designed for R&D leaders, scientific managers and information decision-makers, especially in startups and scaling biotechs, this new white paper demonstrates how the right strategic partner can empower teams with flexible access models, high‑quality research and a future‑ready foundation for high‑velocity discovery.
What 300 R&D Experts Reveal About Access
Download this free whitepaper
Pharmaceutical and biotech teams depend on seamless access to trusted scientific research, yet many still face fragmented discovery workflows, budget pressures and inconsistent institutional access. This white paper reveals how these challenges directly impact innovation—and how subscription-based access to authoritative content can close the gap. Drawing on survey insights from 300 research professionals across North America and Europe, the paper highlights:
-
Why R&D teams increasingly view reliable content access as essential infrastructure
-
The growing disconnect between the value placed on subscriptions and their actual availability
-
The accelerating demand for AI‑enabled tools
